CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
181.32
1.740 0.960%
Share volume: 1,145,084
Last Updated: 03-05-2026
Business Services/Services – Research, Development, Testing Labs:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$179.58
1.74
0.01%
View ratios
| Fiscal Date | 03-30-2024 | 06-29-2024 | 09-28-2024 | 12-28-2024 | 03-29-2025 | 06-28-2025 | 09-27-2025 | 12-27-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-07-2024 | 11-06-2024 | 02-19-2025 | 05-07-2025 | 08-06-2025 | 11-05-2025 | 02-18-2026 | |
| Assets | |||||||||
| Total Assets | 8.153 B | 7.948 B | 8.004 B | 7.528 B | 7.582 B | 7.561 B | 7.514 B | 7.135 B | |
| Current Assets | 1.668 B | 1.499 B | 1.495 B | 1.403 B | 1.506 B | 1.470 B | 1.532 B | 1.447 B | |
| Inventories | 361.281 M | 349.111 M | 336.200 M | 278.544 M | 290.156 M | 279.550 M | 302.550 M | 299.103 M | |
| Other Current Assets | 192.888 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 192.888 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 786.980 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 327.039 M | 179.213 M | 210.171 M | 194.606 M | 229.356 M | 182.824 M | 207.097 M | 213.770 M | |
| Total Non-current Assets | 6.485 B | 231.859 M | 235.987 M | 218.350 M | 214.026 M | 216.073 M | 194.635 M | 206.972 M | |
| Property Plant Equipment | 1.619 B | 1.614 B | 1.640 B | 1.604 B | 1.587 B | 1.607 B | 1.592 B | 1.655 B | |
| Other Assets | 303.147 M | 4.835 B | 4.869 B | 4.521 B | 4.489 B | 4.484 B | 4.390 B | 4.033 B | |
| Intangible Assets | 827.638 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 3.070 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 8.153 B | 7.948 B | 8.004 B | 7.528 B | 7.582 B | 7.561 B | 7.514 B | 7.135 B | |
| Total liabilities | 4.512 B | 4.175 B | 4.176 B | 4.020 B | 4.341 B | 4.161 B | 4.063 B | 3.924 B | |
| Total current liabilities | 954.810 M | 947.519 M | 1.012 B | 994.101 M | 1.051 B | 1.080 B | 1.122 B | 1.120 B | |
| Accounts Payable | 129.682 M | 133.101 M | 135.963 M | 140.337 M | 149.334 M | 145.798 M | 169.615 M | 148.800 M | |
| Other liabilities | 235.441 M | 653.107 M | 669.505 M | 679.001 M | 671.507 M | 638.874 M | 632.647 M | 572.350 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.660 B | 2.409 B | 2.327 B | 2.240 B | 2.511 B | 2.332 B | 2.185 B | 2.136 B | |
| Other liabilities | 235.441 M | 653.107 M | 669.505 M | 679.001 M | 671.507 M | 638.874 M | 632.647 M | 572.350 M | |
| Minority interest | 63.490 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 3.640 B | 3.723 B | 3.782 B | 3.462 B | 3.194 B | 3.353 B | 3.405 B | 3.165 B | |
| Common stock | 51.437 M | 1.957 B | 1.972 B | 1.967 B | 1.979 B | 1.993 B | 2.016 B | 1.948 B | |
| Retained earnings | 1.960 B | 2.054 B | 2.123 B | 1.812 B | 1.838 B | 1.890 B | 1.944 B | 1.389 B |